These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 21779982)
1. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Liu J; Lin Y; Yang H; Deng Q; Chen G; He J Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982 [TBL] [Abstract][Full Text] [Related]
2. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues. Yao Q; Chen J; Lv Y; Wang T; Zhang J; Fan J; Wang L Tumour Biol; 2011 Dec; 32(6):1163-71. PubMed ID: 21861179 [TBL] [Abstract][Full Text] [Related]
3. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer. Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672 [TBL] [Abstract][Full Text] [Related]
4. [Expression of autophagy-related genes Beclin1 and MAPLC3 in non-small cell lung cancer]. Liu Q; Wang JJ; Pan YC; Meng LF; Zhan X; Zheng QF Ai Zheng; 2008 Jan; 27(1):25-9. PubMed ID: 18184459 [TBL] [Abstract][Full Text] [Related]
5. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer. Chen P; Yu J; Knecht J; Chen Q Cancer Epidemiol; 2013 Apr; 37(2):166-71. PubMed ID: 23312889 [TBL] [Abstract][Full Text] [Related]
6. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc. Li HS; Lv RQ; Liu L Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480 [TBL] [Abstract][Full Text] [Related]
7. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis]. Chang C; Wang P; Yang H; Li L; Zhang LB Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548 [TBL] [Abstract][Full Text] [Related]
8. [Expressions and significance of TIMP-3 and mtp53 in non-small cell lung cancer]. Yang H; Li J; Guo J; Zhang S Zhongguo Fei Ai Za Zhi; 2012 Apr; 15(4):202-7. PubMed ID: 22510504 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
10. Loss of Beclin1 Expression and Nrf2 Overexpression are Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer. Yu S; Cheng C; Wang J; Wang J; Qu Z; Ren H; Li Y; Ning Q; Chen M; Hu T Anticancer Agents Med Chem; 2018; 18(12):1680-1687. PubMed ID: 30160218 [TBL] [Abstract][Full Text] [Related]
11. [Expression of P33ING1, P53 and their relationship with apoptosis in anal canal carcinoma]. Chen LS; Li TY; Cao YF; Liang JL; Zhang S; Tang WZ; Tang ZJ; Gao F Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):338-41. PubMed ID: 16886119 [TBL] [Abstract][Full Text] [Related]
12. Autophagy-related genes Raptor, Rictor, and Beclin1 expression and relationship with multidrug resistance in colorectal carcinoma. Shuhua W; Chenbo S; Yangyang L; Xiangqian G; Shuang H; Tangyue L; Dong T Hum Pathol; 2015 Nov; 46(11):1752-9. PubMed ID: 26363527 [TBL] [Abstract][Full Text] [Related]
13. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer. Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591 [TBL] [Abstract][Full Text] [Related]
14. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells]. Fang HL; Yu ZC; Zhu HB; Jin YT Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077 [TBL] [Abstract][Full Text] [Related]
15. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis. Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657 [TBL] [Abstract][Full Text] [Related]
16. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2]. Han PH; Li XJ; Qin H; Yao J; DU N; Ren H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395 [TBL] [Abstract][Full Text] [Related]
17. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis. Qiu Y; Yang H; Chen H; Ge L; Xu X; Xiong X; He J Jpn J Clin Oncol; 2010 Feb; 40(2):146-52. PubMed ID: 19897851 [TBL] [Abstract][Full Text] [Related]
18. Expressions of GRP78 and Bax associate with differentiation, metastasis, and apoptosis in non-small cell lung cancer. Sun Q; Hua J; Wang Q; Xu W; Zhang J; Zhang J; Kang J; Li M Mol Biol Rep; 2012 Jun; 39(6):6753-61. PubMed ID: 22297694 [TBL] [Abstract][Full Text] [Related]
19. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers]. Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642 [TBL] [Abstract][Full Text] [Related]
20. Dysfunction of the p53 tumor suppressor pathway in head and neck cancer. Hoque MO; Kawamata H; Nakashiro K; Omotehara F; Hino S; Uchida D; Harada K; Begum NM; Yoshida H; Sato M; Fujimori T Int J Oncol; 2002 Jul; 21(1):119-26. PubMed ID: 12063558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]